MACROGENICS INC (MGNX)
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.
Address
9704 MEDICAL CENTER DRIVE
Rockville, MD 20850
Founded
2000
Number of Employees
339
Website
http://www.macrogenics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)